We are an international network of healthcare professionals, researchers and consumers producing systematic reviews of evidence for treating cystic fibrosis and other genetic disorders (haemoglobinopathies. coagulopathies and inborn errors of metabolism). Our editorial base is located in Liverpool, UK. 

If you are interested in working with us, please go to Join Cochrane. If you are already a member, please and take a look at our vacant priority titles.

Latest news!

Official opening of our new office

On 11 February 2019 we were delighted to welcome friends old and new to the official opening of our new office, including the Chief Medical Officer for England, Professor Dame Sally Davies and Mr Stephen Briggs. The office has been funded through contributions from the UK CF Trust and the University of Liverpool. We are proud to name it in honour of one of our former editors Dr Sarah Walters OBE who sadly passed away last year. More information about Dr Walters and the event can be read here.

Mr Stephen Briggs (Dr Walters' husband) is pictured here opening the office with Professor Alan Smyth (Co-ordinating Editor), Tracey Remmington and Nikki Jahnke (Managing Editors); with Professor Michael Beresford (Brough Chair, Professor of Child Health at University of Liverpool) and Professor Dame Sally Davies looking on.

Stephen Briggs opens office

Dr Sarah Walters

Guests at opening

Members of Families and Children's Network

Guests at opening

Dr Sarah Walters OBE
1958 - 2018

Mrs Jenny Kelsey, Professor Dame Sally Davies and Mr Stephen BriggsMembers of the CFGD Editorial Team and the Children and Families NetworkProfessor Dame Sally Davies, Professor Rosalind Smyth and Professor Deborah Ashby

Airway clearance techniques for cystic fibrosis: an overview of Cochrane systematic reviews

In our new overview of airway clearance techniques, we compare six different techniques across six separate Cochrane Reviews and summarise their the effectiveness and safety. Find out why we believe that although the reviews were well-conducted, the contributing trials provided low- or very low-quality evidence here.

Gaps in the evidence for treatment decisions in cystic fibrosis: a systematic review

What do we know and what do we know we don't know about CF treatment? Read this new paper in Thorax.

Latest output published on The Cochrane Library
On Issue 3 2020 of The Cochrane Library we have published a total of 196 reviews and 16 protocols. There are also 19 registered titles currently progressing to protocol status. The production of these reviews involves a network of over 1000 contributors (authors, consumers and referees) throughout the world. We very much welcome interest from new consumers, referees and potential reviewers. Further information can be obtained by contacting the group

James Lind AllianceBy getting involved in these priority setting partnerships you can help shape future research. We have already successfully been invovled in a priority setting partnership for CF and you can see the results here. A new priority setting partnership is now open for bleeding disorders and if you have a bleeding disorder and are 8 years of age or older, or if you are a carer for someone with a bleeding disorder, we strongly encourage you to participate. Clinicians and other health professionals are welcome to participate too. More information can be found here.